SUFU and endometrial cancer: Accordingly, the expression of SUFU, Gli2, and PTCH2 should be theoretically regulated by NOMAC in the endometrial cancer; however, our RT-qPCR results showed that the mRNA levels of Gli2 and PTCH2 did not change significantly as SUFU upregulation, and they were inconsistent with cDNA microarray analysis.